Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Pfizer's (PFE) Hemophilia B Gene Therapy Meets Study Goal
11:17am, Friday, 30'th Dec 2022
Data from a late-stage study shows that treatment with Pfizer's (PFE) hemophilia B gene therapy resulted in a 71% reduction in annualized bleed rate (ABR) compared to standard-of-care treatment.
5 High Yield Dividend Income Stocks For 2023
07:00pm, Thursday, 29'th Dec 2022
Investing in dividend income stocks allows you to generate an extra income that can be used for your monthly expenses. However, you need to be careful: a company with a very high Dividend Yield could
Pfizer (PFE) Pentavalent Meningitis Jab BLA Gets FDA Acceptance
10:32am, Thursday, 29'th Dec 2022
The FDA assigns a standard review to Pfizer's (PFE) BLA for pentavalent meningococcal vaccine candidate (MenABCWY), with a decision expected in October 2023.
Pfizer's hemophilia B treatment meets primary endpoint in Phase 3 study
07:20am, Thursday, 29'th Dec 2022
Pfizer Inc. said Thursday that a Phase 3 study of fidanacogene elaparvovec for the treatment of hemophilia B in adult males met its primary endpoint of superiority in the annualized bleeding rate (ABR
Big Health Care Stocks to Watch in the New Year
01:01am, Thursday, 29'th Dec 2022
Here are three health care stocks to watch as the New Year begins. Two have a moderate Buy rating while one is a Hold, for now.
Pfizer Makes Progress, but This Biotech Was Wednesday's Big Winner
06:35pm, Wednesday, 28'th Dec 2022
The stock market lost ground as economic worries persist.
Grade My Trade: CRM, PFE & ENPH
02:01pm, Wednesday, 28'th Dec 2022
The ‘Halftime Report' investment committee, Kari Firestone, Rob Sechan, Joe Terranova and Jim Lebenthal, weigh in on the Salesforce, Pfizer and Enphase Energy.
Best Value Stocks To Buy For 2023? 3 To Watch
04:59pm, Tuesday, 27'th Dec 2022
Are these the best value stocks to buy for 2023?
3 Stocks That Could Soar in a Santa Claus Rally
07:45am, Sunday, 25'th Dec 2022
These stocks are primed for a holiday surge.
Stuff Your Stocking With These Smart Buys Before 2023
05:30am, Sunday, 25'th Dec 2022
These gifts may keep on giving over the long term.
Pfizer's (PFE) Etrasimod Filings Receive Review Acceptance
12:48pm, Thursday, 22'nd Dec 2022
The regulatory filings seek approval for Pfizer's (PFE) etrasimod in UC indication. A final decision in the U.S. is expected in 2023, while the decision in the EU is expected in 2024.
ORIC Rises on Team-Up With Pfizer for Multiple Myeloma Study
12:48pm, Thursday, 22'nd Dec 2022
ORIC inks a collaboration deal with Pfizer for a phase II study evaluating ORIC-533 in combination with the latter's elranatamab in multiple myeloma. Stock up in after-hours trading.
Oric's stock rallies on multiple myeloma deal with Pfizer
08:38am, Thursday, 22'nd Dec 2022
Shares of Oric Pharmaceuticals Inc. ORIC, +2.04% soared about 56% in premarket trading on Thursday, the day after the company said it will collaborate with Pfizer Inc. PFE, +0.66% to develop a multipl
ORIC Pharmaceuticals (ORIC) Stock Rockets 58% on Pfizer Deal
08:25am, Thursday, 22'nd Dec 2022
ORIC Pharmaceuticals (NASDAQ: ORIC ) stock is rocketing higher after the company revealed a collaboration deal with Pfizer (NYSE: PFE ). The big news here is ORIC Pharmaceuticals and Pfizer working to
5 Stocking Stuffer Stocks for Christmas 2022
02:46pm, Wednesday, 21'st Dec 2022
The end of the year is often a time for investors to buy and sell stocks and clean up their portfolios. Some investors allocate excess cash to new investments or add to existing holdings.
